Cutting Edge Spine Gains FDA Clearance of EVOLha-DLIF

Cutting Edge Spine (CES) received FDA 510(k) clearance of the EVOL®ha-DLIF direct lateral interbody fusion system, its latest addition to a bioactive device portfolio. Product launch is underway.

Like the company's EVOLha-C, EVOLha-ALIF and EVOSha, EVOLha-DLIF is made of PEEK-OPTIMA HA Enhanced material from Invibio Biomaterial Solutions....

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us